✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹297 Cr.
P/E
22.23

Key Ratios

Market cap
Market cap
297 Cr
PE
PE
22.23
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
36.98
ROCE (%)
ROCE (%)
49.41
Div Yield (%)
Div Yield (%)
-
Sales
Sales
104 Cr
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
0.01
About
Influx Healthtech is a reliable Contract Development and Manufacturing Organization (CDMO) spe… Read more
Low
120
52W Range
High
140
  • Influx Healthtech
  • Sudarshan Pharma Ind
  • Quest Laboratories

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

4 Yes

Positive for this company

3 Neutral

Neutral for this company

1 No

Negative for this company

9 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up - India

Location Wise Break-Up

Peer Comparison
FAQs on Influx Healthtech Ltd. Business

Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. The company is a reliable Contract Development and Manufacturing Organization (CDMO), providing specialized services to clients in multiple industries. The company has diversified product portfolio.

Influx Healthtech major competitors are Sudarshan Pharma Ind, Quest Laboratories.
Market Cap of Influx Healthtech is ₹313 Crs.
While the median market cap of its peers are ₹428 Crs.

Influx Healthtech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material